Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gallagher

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Scientific Reports|June 30, 2021
The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome populationSarah E Pape, Tamara Al Janabi, Nicholas J Ashton, et al.
Archives of Biochemistry and Biophysics|August 9, 2005
Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxinPaul Gallagher, Yongde Bao, Solange M T Serrano, et al.
Journal for Immunotherapy of Cancer|January 18, 2019
Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrenceKatey S S Enfield, Spencer D Martin, Erin A Marshall, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
Therapeutic Advances in Drug Safety|January 11, 2018
Incident adverse drug reactions in geriatric inpatients: a multicentred observational studyAmanda Lavan, Joseph Eustace, Darren Dahly, et al.
Social Science & Medicine (1982)|December 23, 2023
'Ageing well': Discursive constructions of ageing and health in the public reach of a national longitudinal study on ageingGerard Fealy, Matteo Di Placido, Deirdre O'Donnell, et al.
Psychology, Health & Medicine|September 23, 2024
From the ground up: stakeholders' representations of the Irish longitudinal study on ageing (TILDA)Yeter Sinem Üzar-Özçetin, Michael Connolly, Timmy Frawley, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Age and Ageing|June 24, 2021
Corrigendum to: Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trialDenis O'Mahony, Adalsteinn Gudmundsson, Roy L Soiza, et al.
Age and Ageing|June 3, 2020
Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trialDenis O'Mahony, Adalsteinn Gudmundsson, Roy L Soiza, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Scientific Reports|June 30, 2021
The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome populationSarah E Pape, Tamara Al Janabi, Nicholas J Ashton, et al.
Archives of Biochemistry and Biophysics|August 9, 2005
Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxinPaul Gallagher, Yongde Bao, Solange M T Serrano, et al.
Journal for Immunotherapy of Cancer|January 18, 2019
Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrenceKatey S S Enfield, Spencer D Martin, Erin A Marshall, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
Therapeutic Advances in Drug Safety|January 11, 2018
Incident adverse drug reactions in geriatric inpatients: a multicentred observational studyAmanda Lavan, Joseph Eustace, Darren Dahly, et al.
Social Science & Medicine (1982)|December 23, 2023
'Ageing well': Discursive constructions of ageing and health in the public reach of a national longitudinal study on ageingGerard Fealy, Matteo Di Placido, Deirdre O'Donnell, et al.
Psychology, Health & Medicine|September 23, 2024
From the ground up: stakeholders' representations of the Irish longitudinal study on ageing (TILDA)Yeter Sinem Üzar-Özçetin, Michael Connolly, Timmy Frawley, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Age and Ageing|June 24, 2021
Corrigendum to: Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trialDenis O'Mahony, Adalsteinn Gudmundsson, Roy L Soiza, et al.
Age and Ageing|June 3, 2020
Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trialDenis O'Mahony, Adalsteinn Gudmundsson, Roy L Soiza, et al.
Pageof 10